Newer oral GLP-1 options like the Wegovy pill are more affordable currently around $149 per month but clinical trials show they deliver somewhat less weight loss than injectables, averaging around 1516% compared to 20% or more with injections. For patients who need significant weight loss to resolve health conditions, a lower-cost medication that produces fewer results may not be enough
In particular, nausea (affecting up to 50% of patients) and diarrhoea (more than 10%) are very common, and vomiting, abdominal pain, dyspepsia and constipation (1 to 10%) are common
It's crucial to maintain the protocol and resist the urge to increase the dosage
You will have peace of mind knowing that your medication has been compounded by a trusted pharmacy professional and is not only safe, but effective
One of the key benefits of Ipamorelin over older peptides like GHRP-6 is that it does not significantly elevate ghrelin levels
Oral options are emerging quickly, including oral semaglutide formulations and orforglipron, marketed as Foundayo